Silicon Laboratories, Inc. $SLAB Position Reduced by Federation des caisses Desjardins du Quebec

Key Points

• The Federation des caisses Desjardins du Quebec sold 8,033 shares of Silicon Laboratories, reducing its stake by 30% to 18,700 shares, which are worth approximately $2.1 million.
• Multiple institutional investors increased their stakes in Silicon Laboratories, with UMB Bank n.a. growing its position by 111.3% during the first quarter.
• Analysts have mixed opinions on Silicon Laboratories, with price targets ranging from $144.00 to $160.00, and a consensus rating of "Moderate Buy."

Federation des caisses Desjardins du Quebec lowered its holdings in Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report) by 30.0% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 18,700 shares of the semiconductor company's stock after selling 8,033 shares during the period. Federation des caisses Desjardins du Quebec owned about 0.06% of Silicon Laboratories worth $2,105,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Cubist Systematic Strategies LLC acquired a new position in Silicon Laboratories during the 1st quarter valued at approximately $1,033,000. Quarry LP acquired a new position in shares of Silicon Laboratories during the first quarter valued at $25,000. State of Wyoming increased its holdings in shares of Silicon Laboratories by 6.0% in the 1st quarter. State of Wyoming now owns 2,264 shares of the semiconductor company's stock worth $255,000 after acquiring an additional 128 shares during the period. PEAK6 LLC acquired a new stake in shares of Silicon Laboratories in the 1st quarter worth about $867,000. Finally, FORA Capital LLC bought a new stake in Silicon Laboratories in the 1st quarter valued at about $222,000.

Insider Buying and Selling at Silicon Laboratories

In related news, SVP Brandon Tolany sold 1,800 shares of Silicon Laboratories stock in a transaction on Friday, August 29th. The stock was sold at an average price of $133.57, for a total value of $240,426.00. Following the transaction, the senior vice president directly owned 62,328 shares in the company, valued at $8,325,150.96. The trade was a 2.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Over the last three months, insiders sold 12,070 shares of company stock worth $1,703,472. Company insiders own 1.60% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on SLAB. Needham & Company LLC restated a "buy" rating and issued a $150.00 price target on shares of Silicon Laboratories in a research note on Wednesday, May 14th. KeyCorp raised their target price on Silicon Laboratories from $160.00 to $180.00 and gave the company an "overweight" rating in a research report on Tuesday, July 8th. Susquehanna lifted their target price on Silicon Laboratories from $110.00 to $150.00 and gave the company a "neutral" rating in a research note on Tuesday, July 22nd. Barclays boosted their price target on Silicon Laboratories from $100.00 to $130.00 and gave the stock an "equal weight" rating in a research report on Tuesday, August 5th. Finally, Wall Street Zen raised Silicon Laboratories from a "sell" rating to a "hold" rating in a report on Wednesday, May 14th. Five analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $151.13.

Silicon Laboratories Stock Performance

Shares of NASDAQ:SLAB traded up $2.39 during trading hours on Thursday, hitting $134.61. 73,895 shares of the company's stock traded hands, compared to its average volume of 394,680. The company's fifty day simple moving average is $136.52 and its two-hundred day simple moving average is $126.61. The company has a market cap of $4.42 billion, a price-to-earnings ratio of -41.68 and a beta of 1.52. Silicon Laboratories, Inc. has a 52 week low of $82.82 and a 52 week high of $160.00.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last released its earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 EPS for the quarter, beating the consensus estimate of $0.09 by $0.02. The business had revenue of $192.85 million during the quarter, compared to analyst estimates of $192.57 million. Silicon Laboratories had a negative net margin of 14.88% and a negative return on equity of 7.21%. The business's quarterly revenue was up 32.6% on a year-over-year basis. During the same period in the prior year, the business earned ($0.56) earnings per share. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. On average, analysts anticipate that Silicon Laboratories, Inc. will post -0.97 EPS for the current fiscal year.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.